According to Insider Monkey’s Q3 database, 12 hedge funds were bullish on Takeda Pharmaceutical Company Limited (NYSE:TAK), an increase from 10 funds in the last quarter. Israel Englander’s ...

According to Insider Monkey’s Q3 database, 12 hedge funds were bullish on Takeda Pharmaceutical Company Limited (NYSE:TAK), an increase from 10 funds in the last quarter. Israel Englander’s ...

June 21, 2024 Takeda gives Sun Pharma ... February 2, 2024 India's Torrent Pharma posts higher Q3 profit on strong domestic demand Indian drugmaker Torrent Pharmaceuticals reported a 30% rise ...

The company made $34M in revenues in Q3 22, for a net loss of $10M ... in partnership with Nestle and Takeda. The company is active in human gene editing, developing modified cells to treat patients.

Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology. BridGene’s pursuit of undruggable targets is enabled ...

Takeda’s (NYSE: TAK) (TSE:4502) plasma-derived therapies (PDT) business, led by Giles Platford, president of Takeda’s Plasma-Derived Therapies Business Unit and chair of the Plasma Protein ...

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...

On Monday, Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and Takeda Pharmaceutical Co Ltd (NYSE:TAK) released topline results for the Phase 3 VERIFY study of rusfertide for polycythemia vera.

Q3 Results, Earnings Today: Today, companies like Swiggy, Reliance Power, Page Industries, Kansai Nerolac Paints, Arvind Fashions, and several others are releasing their Q3 numbers. (Image Source ...